Anti-inflammation-based treatment of atherosclerosis using Gliclazide-loaded biomimetic nanoghosts
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource, 1 online resource.
- Sprache
-
Englisch
- Erschienen in
-
Anti-inflammation-based treatment of atherosclerosis using Gliclazide-loaded biomimetic nanoghosts ; volume:13 ; number:1 ; day:24 ; month:8 ; year:2023 ; pages:1-12 ; date:12.2023
Scientific reports ; 13, Heft 1 (24.8.2023), 1-12, 12.2023
- Urheber
-
Karami, Zahra
Mehrzad, Jalil
Akrami, Mohammad
Hosseinkhani, Saman
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-023-41136-y
- URN
-
urn:nbn:de:101:1-2023110610071453063098
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:44 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Karami, Zahra
- Mehrzad, Jalil
- Akrami, Mohammad
- Hosseinkhani, Saman
- SpringerLink (Online service)
Ähnliche Objekte (12)
Biomimetic Nanocarriers of Pro‐Resolving Lipid Mediators for Resolution of Inflammation in Atherosclerosis
Reactive oxygen species scavenging and inflammation mitigation enabled by biomimetic prussian blue analogues boycott atherosclerosis
Shear stress, inflammation and Atherosclerosis
Evolocumab loaded Bio-Liposomes for efficient atherosclerosis therapy
Biomimetic Platelet‐Cloaked Nanoparticles for the Delivery of Anti‐Inflammatory Curcumin in the Treatment of Atherosclerosis
Macrophage biomimetic nanocarriers for anti-inflammation and targeted antiviral treatment in COVID-19
Linking inflammation and atherosclerosis – novel mechanistic insights into how vascular inflammation fuels progression of atherosclerosis –
Targeting Inflammation in Atherosclerosis Using Colchicine
Inflammation in atherosclerosis: pathophysiology and mechanisms
Tyrosine kinase inhibitor-loaded biomimetic nanoparticles as a treatment for osteosarcoma
Anti-reflective and anti-bacterial properties of biomimetic nanostructures
Anti-Reflective and Anti-Bacterial Properties of Biomimetic Nanostructures
Biomimetic Nanocarriers of Pro‐Resolving Lipid Mediators for Resolution of Inflammation in Atherosclerosis
Reactive oxygen species scavenging and inflammation mitigation enabled by biomimetic prussian blue analogues boycott atherosclerosis
Shear stress, inflammation and Atherosclerosis
Evolocumab loaded Bio-Liposomes for efficient atherosclerosis therapy
Biomimetic Platelet‐Cloaked Nanoparticles for the Delivery of Anti‐Inflammatory Curcumin in the Treatment of Atherosclerosis
Macrophage biomimetic nanocarriers for anti-inflammation and targeted antiviral treatment in COVID-19
Linking inflammation and atherosclerosis – novel mechanistic insights into how vascular inflammation fuels progression of atherosclerosis –
Targeting Inflammation in Atherosclerosis Using Colchicine
Inflammation in atherosclerosis: pathophysiology and mechanisms
Tyrosine kinase inhibitor-loaded biomimetic nanoparticles as a treatment for osteosarcoma
Anti-reflective and anti-bacterial properties of biomimetic nanostructures
Anti-Reflective and Anti-Bacterial Properties of Biomimetic Nanostructures
Biomimetic Nanocarriers of Pro‐Resolving Lipid Mediators for Resolution of Inflammation in Atherosclerosis
Reactive oxygen species scavenging and inflammation mitigation enabled by biomimetic prussian blue analogues boycott atherosclerosis
Shear stress, inflammation and Atherosclerosis
Evolocumab loaded Bio-Liposomes for efficient atherosclerosis therapy
Biomimetic Platelet‐Cloaked Nanoparticles for the Delivery of Anti‐Inflammatory Curcumin in the Treatment of Atherosclerosis
Macrophage biomimetic nanocarriers for anti-inflammation and targeted antiviral treatment in COVID-19
Linking inflammation and atherosclerosis – novel mechanistic insights into how vascular inflammation fuels progression of atherosclerosis –
Targeting Inflammation in Atherosclerosis Using Colchicine
Inflammation in atherosclerosis: pathophysiology and mechanisms
Tyrosine kinase inhibitor-loaded biomimetic nanoparticles as a treatment for osteosarcoma
Anti-reflective and anti-bacterial properties of biomimetic nanostructures